Remember, GLP-1 triggers insulin secretion and blocks the release of glucagon
They are also exactly how high severity events become surprises. Robust medication governance requires: Consistency in disclosure Clarity in written and verbal education Defined escalation instructions Documentation of counseling Feedback loops when adverse events occur In other words, a serious but uncommon risk needs a standardized workflow
Side effects, including nausea (44% vs 44%), constipation (28% vs 29%), diarrhea (24% vs 23%), and vomiting (15% vs 21%), were similar between groups and mainly occurred during the therapy titration phase
GLP-1s (Semaglutide & Tirzepatide) Reduces appetite and food noise Weekly injection or oral option Most patients lose 1530% of body weight Helps stabilize blood sugar and improve metabolism Includes complimentary B12 or B12-MIC injection Oral Medications (e.g
L-Carnitine: Metabolic Enhancer L-Carnitine is often included to support how the body utilizes stored fat for energy
My Doctor Online